FLKS Flex Pharma Inc.

+0.01  (+2%)
Previous Close 0.53
Open 0.54
Price To Book 1.06
Market Cap 9757517
Shares 18,069,476
Volume 554,657
Short Ratio
Av. Daily Volume 1,378,857

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial terminated - noted June 13, 2018.
FLX-787 - COMMEND US trial
Amyotrophic lateral sclerosis (ALS)
Phase 2 trial terminated - noted June 13, 2018.
Charcot-Marie-Tooth (CMT)
Phase 2 endpoints not met - October 2016. Announced January 24, 2017 that other indications will take priority over nocturnal leg cramps.
Nocturnal Leg Cramp
Phase 2 data released March 26, 2018 - 27% decrease in spasms.
FLX-787 (Aust)
Multiple Sclerosis

Latest News

  1. Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation
  2. Flex Pharma Reports Fourth Quarter and Fiscal 2018 Financial Results
  3. Houston oncology co. aims to grow after merger announcement
  4. SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flex Pharma, Inc. - FLKS
  5. Deal of the Week: Houston oncology co. to merge with struggling pharma co. in Boston
  6. Houston oncology co. to merge with Boston’s struggling Flex Pharma
  7. FLKS News: Flex Pharma Stock Rockets Higher on Salarius Merger
  8. Flex Pharma Finds A Lifeline In Merger With Oncology Biotech Salarius Pharma
  9. 4 Healthcare Stocks To Watch On Friday (1/4/19)
  10. Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
  11. Before You Buy Flex Pharma, Inc. (NASDAQ:FLKS), Consider Its Volatility
  12. Asceneuron Appoints Dr. Thomas C. Wessel as Chief Medical Officer
  13. Analysis: Positioning to Benefit within Independence Holding, KVH Industries, Attunity, Flex Pharma, Westinghouse Air Brake Technologies, and Alaska Communications Systems Group — Research Highlights Growth, Revenue, and Consolidated Results
  14. Flex Pharma: 3Q Earnings Snapshot
  15. Flex Pharma Reports Third Quarter 2018 Financial Results
  16. 3 Healthcare Tech Stocks To Watch In November
  17. Flex Pharma Refocuses Goals for FLX-787 and Develops HOTSHOT Market, Analysts Review
  18. 10 Hottest Stocks From October 16, 2018
  19. Today's Research Reports on Trending Tickers: Flex Pharma and Dr. Reddy's Laboratories